559 related articles for article (PubMed ID: 437169)
21. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
22. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
24. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of experimental lactational mammary gland growth in the rat with exogenous estrogen and progesterone.
Ferreri LF; Griffith DR
Proc Soc Exp Biol Med; 1977 Jul; 155(3):429-32. PubMed ID: 877143
[TBL] [Abstract][Full Text] [Related]
26. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
27. Cardiopulmonary effects of progestational agents in emphysematous rats.
Ino T; Aviado DM
Chest; 1971 Jun; 59(6):659-66. PubMed ID: 5087936
[TBL] [Abstract][Full Text] [Related]
28. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
Parkington HC; Lipton A
J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
30. The effect of an oral contraceptive on tests of thyroid function.
Mishell DR; Colodny SZ; Swanson LA
Fertil Steril; 1969; 20(2):335-9. PubMed ID: 4179961
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic study of different doses of Depo Provera.
Fotherby K; Koetsawang S; Mathrubutham M
Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
33. Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity, and serum hormone concentrations.
Kokko E; Jänne O; Kauppila A; Vihko R
Am J Obstet Gynecol; 1982 Jun; 143(4):382-8. PubMed ID: 6211985
[No Abstract] [Full Text] [Related]
34. Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera.
Mora G; Johansson ED
Contraception; 1976 Sep; 14(3):343-50. PubMed ID: 824097
[TBL] [Abstract][Full Text] [Related]
35. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
[TBL] [Abstract][Full Text] [Related]
36. [Concentration of estrone, estradiol and estriol in the blood of pregnant sheep after induction of estrus with chlormadinone acetate and medroxyprogesterone acetate].
Halagan J; Arendarcik J
Vet Med (Praha); 1976 Sep; 21(9):551-6. PubMed ID: 66795
[TBL] [Abstract][Full Text] [Related]
37. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
Kekkonen R; Croxatto HB; Lähteenmäki P; Salvatierra AM; Tuominen J
Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
[TBL] [Abstract][Full Text] [Related]
38. Mammary nodules in dogs during four years' treatment with megestrol acetate or chlormadinone acetate.
Nelson LW; Weikel JH; Reno FE
J Natl Cancer Inst; 1973 Oct; 51(4):1303-11. PubMed ID: 4126857
[TBL] [Abstract][Full Text] [Related]
39. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
Spellacy WN; Kalra PS; Buhi WC; Birk SA
Am J Obstet Gynecol; 1980 May; 137(1):109-15. PubMed ID: 6768295
[TBL] [Abstract][Full Text] [Related]
40. In vitro steroid metabolic studies in human testes I: Effects of estrogen on progesterone metabolism.
Rodriguez-Rigau LJ; Tcholakian RK; Smith KD; Steinberger E
Steroids; 1977 Jun; 29(6):771-86. PubMed ID: 910250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
